Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795–1809. https://doi.org/10.1016/S0140-6736(06)69740-7
Article CAS PubMed Google Scholar
Daiger SP, Sullivan LS, Bowne SJ (2013) Genes and mutations causing retinitis pigmentosa. Clin Genet 84:132–141. https://doi.org/10.1111/cge.12203
Article CAS PubMed Google Scholar
Adackapara CA, Sunness JS, Dibernardo CW, Melia BM, Dagnelie G (2008) Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina 28:103–110. https://doi.org/10.1097/IAE.0b013e31809862aa
Hajali M, Fishman GA (2009) The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 23:915–919. https://doi.org/10.1038/eye.2008.110
Article CAS PubMed Google Scholar
Hajali M, Fishman GA, Anderson RJ (2008) The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol 92:1065–1068. https://doi.org/10.1136/bjo.2008.138560
Article CAS PubMed Google Scholar
Testa F, Rossi S, Colucci R, Gallo B, Di Iorio V, della Corte M, Azzolini C, Melillo P, Simonelli F (2014) Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol 98:946–950. https://doi.org/10.1136/bjophthalmol-2013-304082
Karasu B (2020) Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors. Int Ophthalmol 40:677–687. https://doi.org/10.1007/s10792-019-01228-z
Blank T, Goldmann T, Koch M, Amann L, Schon C, Bonin M, Pang S, Prinz M, Burnet M, Wagner JE, Biel M, Michalakis S (2017) Early microglia activation precedes photoreceptor degeneration in a mouse model of CNGB1-linked retinitis pigmentosa. Front Immunol 8:1930. https://doi.org/10.3389/fimmu.2017.01930
Article CAS PubMed Google Scholar
Zhao L, Zabel MK, Wang X, Ma W, Shah P, Fariss RN, Qian H, Parkhurst CN, Gan WB, Wong WT (2015) Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med 7:1179–1197. https://doi.org/10.15252/emmm.201505298
Article CAS PubMed PubMed Central Google Scholar
Peng B, Xiao J, Wang K, So KF, Tipoe GL, Lin B (2014) Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa. J Neurosci 34:8139–8150. https://doi.org/10.1523/JNEUROSCI.5200-13.2014
Article CAS PubMed PubMed Central Google Scholar
Cukras CA, Petrou P, Chew EY, Meyerle CB, Wong WT (2012) Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study. Invest Ophthalmol Vis Sci 53:3865–3874. https://doi.org/10.1167/iovs.11-9413
Article CAS PubMed PubMed Central Google Scholar
Chung YR, Kim YH, Lee SY, Byeon HE, Lee K (2019) Insights into the pathogenesis of cystoid macular edema: leukostasis and related cytokines. Int J Ophthalmol 12:1202–1208. https://doi.org/10.18240/ijo.2019.07.23
Article PubMed PubMed Central Google Scholar
Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T (2013) Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:e5-12. https://doi.org/10.1016/j.ophtha.2012.07.008
Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769–15774. https://doi.org/10.1073/pnas.95.26.15769
Article CAS PubMed PubMed Central Google Scholar
Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496–13500. https://doi.org/10.1073/pnas.96.23.13496
Article CAS PubMed PubMed Central Google Scholar
Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559–1565. https://doi.org/10.2337/diabetes.54.5.1559
Article CAS PubMed Google Scholar
Genead MA, Fishman GA (2010) Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 128:1146–1150. https://doi.org/10.1001/archophthalmol.2010.172
Article CAS PubMed PubMed Central Google Scholar
Fishman GA, Apushkin MA (2007) Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 91:743–745. https://doi.org/10.1136/bjo.2006.107466
Article PubMed PubMed Central Google Scholar
Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA (1994) Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101:687–693. https://doi.org/10.1016/s0161-6420(94)31277-2
Article CAS PubMed Google Scholar
Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107:1445–1452. https://doi.org/10.1001/archopht.1989.01070020519031
Article CAS PubMed Google Scholar
Fishman GA, Glenn AM, Gilbert LD (1993) Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111:1640–1646. https://doi.org/10.1001/archopht.1993.01090120062023
Article CAS PubMed Google Scholar
Asahi MG, BobarnacDogaru GL, Onishi SM, Gallemore RP (2015) Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema. Int Med Case Rep J 8:305–312. https://doi.org/10.2147/IMCRJ.S92794
Article PubMed PubMed Central Google Scholar
Ikeda Y, Hisatomi T, Yoshida N, Notomi S, Murakami Y, Enaida H, Ishibashi T (2012) The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 250:809–814. https://doi.org/10.1007/s00417-011-1904-5
Article CAS PubMed Google Scholar
Liew G, Moore AT, Webster AR, Michaelides M (2015) Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci 56:1531–1536. https://doi.org/10.1167/iovs.14-15995
Article CAS PubMed Google Scholar
Yeo JH, Min CH, Yoon YH (2022) Effect of oral carbonic anhydrase inhibitor on cystoid macular edema associated with retinitis pigmentosa: an OCT and OCT angiography study. Retina 42:1796–1804. https://doi.org/10.1097/IAE.0000000000003531
Article CAS PubMed PubMed Central Google Scholar
Shimokawa S, Murakami Y, Fujiwara K, Funatsu J, Nakatake S, Koyanagi Y, Akiyama M, Yoshida N, Takeda A, Ikeda Y, Sonoda KH (2022) Recurrence rate of cystoid macular edema with topical dorzolamide treatment and its risk factors in retinitis pigmentosa. Retina 42:168–173. https://doi.org/10.1097/IAE.0000000000003286
Article CAS PubMed Google Scholar
Kitahata S, Hirami Y, Takagi S, Kime C, Fujihara M, Kurimoto Y, Takahashi M (2018) Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa. BMJ Open Ophthalmol 3:e000107. https://doi.org/10.1136/bmjophth-2017-000107
Article PubMed PubMed Central Google Scholar
Park UC, Park JH, Ma DJ, Cho IH, Oh BL, Yu HG (2020) A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa. Retina 40:1359–1366. https://doi.org/10.1097/IAE.0000000000002589
Veritti D, Sarao V, De Nadai K, Chizzolini M, Parmeggiani F, Perissin L, Lanzetta P (2020) Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa. J Ocul Pharmacol Ther 36:190–197. https://doi.org/10.1089/jop.2018.0153
Article CAS PubMed Google Scholar
Strong SA, Peto T, Bunce C, Xing W, Georgiou M, Esposti SD, Kalitzeos A, Webster A, Michaelides M (2020) Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa. Br J Ophthalmol 104:1203–1208. https://doi.org/10.1136/bjophthalmol-2019-315152
Shah CR, Brent MH (2010) Treatment of retinitis pigmentosa-related cystoid macular edema with intravitreous ranibizumab. Retin Cases Brief Rep 4:291–293. https://doi.org/10.1097/ICB.0b013e3181af7b6c
留言 (0)